Nu-Med Plus Draws Global Attention as MERS, SARS and Bird Flu Threats Continue to Increase
(firmenpresse) - SALT LAKE CITY, UT -- (Marketwired) -- 07/07/15 -- Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has drawn worldwide attention with the increased threats to national economies coming from the spread of MERS, SARS and the Bird Flu.
Jeff Robins, President and CEO of Nu-Med Plus, Inc., remarked, "Because Nitric Oxide gas has been extensively studied internationally and shown to be effective on numerous modalities, and with the outbreaks of MERS, SARS and the Bird Flu worldwide, Nu-Med Plus has received numerous inquiries and communications from international Medical Device companies as well as distributors about our products while they pursue solutions. I think it's important for our shareholders to understand that Inhaled Nitric Oxide is FDA approved here in the United States. Also, that it is our medical devices that deliver cost effective Inhaled Nitric Oxide to patients in a manner unique to the market that is generating so much interest."
Mr. Robins went on to say, "As a company we believe it is important to evaluate those business opportunities outside of the United States, so long as we do not lose focus on our main objectives here in the U.S. We are working hard as a company to increase our intellectual property portfolio with patent filings for Inhaled Nitric Oxide delivery technology as well as preparations for our impending FDA medical device applications."
About Nu-Med Plus, Inc.
Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to focus on high growth potential markets where there is a clearly defined need recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of nitric oxide gas for therapeutic use. For more company information please visit .
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's ability to complete proposed private placement financing. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.
Contact:
Jeff Robins
President
801-746-3570
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.07.2015 - 12:00 Uhr
Sprache: Deutsch
News-ID 405069
Anzahl Zeichen: 0
contact information:
Town:
SALT LAKE CITY, UT
Kategorie:
Hospitals, Facilities and Providers
Diese Pressemitteilung wurde bisher 197 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Nu-Med Plus Draws Global Attention as MERS, SARS and Bird Flu Threats Continue to Increase"
steht unter der journalistisch-redaktionellen Verantwortung von
Nu-Med Plus, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
